Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Mar;39(2):157-65.
doi: 10.1188/12.ONF.157-165.

Gastrointestinal symptom representation in cancer symptom clusters: a synthesis of the literature

Affiliations
Review

Gastrointestinal symptom representation in cancer symptom clusters: a synthesis of the literature

Catherine H Cherwin. Oncol Nurs Forum. 2012 Mar.

Abstract

Purpose/objectives: To review how gastrointestinal (GI)symptoms are represented within symptom clusters in patients with cancer receiving chemotherapy.

Data sources: MedLINE, PsycINFO, and CINAHL.

Data synthesis: Forty-two symptom clusters containing a GI component emerged. Only four clusters were replicated in different samples; 38 were unique clusters. Thirteen different symptom measurement tools were used across the studies. Nineteen different GI symptoms were measured; however, many chemotherapy- or cancer-related GI symptoms known to be present in this population were missing or underrepresented. Twenty-one of the studies reviewed identified a symptom cluster that was primarily (50% or greater) composed of GI symptoms.

Conclusions: GI symptoms are prevalent in symptom clusters, but those clusters often are inconsistent. One explanation for this finding may be that current symptom measurement tools do not fully address GI symptoms commonly experienced by patients receiving chemotherapy.

Implications for nursing: Future research should focus on using a comprehensive symptom assessment tool in a homogenous sample of participants who are receiving chemotherapy. Improved measurement of GI symptoms will advance symptom cluster research, which could impact assessment of chemotherapy-related symptoms and development of interventions for symptom clusters.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Armstrong TS, Gning I, Mendoza T, Vera-Bolanos E, Gilbert MR, Rhines LD, Cleeland CS. Reliability and validity of the M.D. Anderson Symptom Inventory—Spine Tumor Module. Journal of Neurosurgery: Spine. 2010;12:421–430. doi: 10.3171/2009.10.SPINE0943. - DOI - PubMed
    1. Baker PD, Morzorati SL, Ellett ML. The pathophysiology of chemotherapy-induced nausea and vomiting. Gastroenterology Nursing. 2005;28:469–480. - PubMed
    1. Barresi MJ, Shadbolt B, Byrne D, Stuart-Harris R. The development of the Canberra Symptom Scorecard: A tool to monitor the physical symptoms of patients with advanced tumours. BMC Cancer. 2003;3:32–41. doi: 10.1186/1471-2407-3-32. - DOI - PMC - PubMed
    1. Barsevick AM, Whitmer K, Nail LM, Beck SL, Dudley WN. Symptom cluster research: Conceptual, design, measurement, and analysis issues. Journal of Pain and Symptom Management. 2006;31:85–95. - PubMed
    1. Berger AM, Clark-Snow RA. Chemotherapy-related nausea and vomiting. In: Berger AM, Shuster JL Jr, von Roenn JH, editors. Principles and practice of palliative care and supportive oncology. Philadelphia, PA: Lippincott-Raven; 2007. pp. 139–149.

Publication types

MeSH terms

Substances